A: 'Saheli' - a new oral contraceptive for fe | vedclass

Name: Exam Paper Generator | JEE NEET Paper Generator | Vedclass
Brand: Vedclass
Rating: 5 (35 reviews)

Question

(A) Assertion $(A)$ is correct: 'Saheli' is a non-steroidal oral contraceptive pill developed by the Central Drug Research Institute $(CDRI)$ in Luckn

Vedclass · Accepted Answer

Assertion and Reason both are correct and Reason is the correct explanation of Assertion.

Vedclass · Answer

(A) Assertion $(A)$ is correct: 'Saheli' is a non-steroidal oral contraceptive pill developed by the Central Drug Research Institute $(CDRI)$ in Lucknow,India.Reason $(R)$ is correct: 'Saheli' contains a compound called centchroman,which is non-steroidal in nature.Since the non-steroidal nature of 'Saheli' is the reason why it is considered a unique and safer alternative to conventional hormonal (steroidal) pills,the Reason correctly explains the Assertion.

$A$: 'Saheli' - a new oral contraceptive for females was developed at $CDRI$,Lucknow.
$R$: It contains no steroids.

Similar Questions

Contraceptive method,having least side effect is $:-$

The rhythm method of temporary contraception is based on which feature of the menstrual cycle?

Oral contraceptives prevent:

Give information about natural methods useful as contraceptives.

Multiload $375$ is a . . . . . . type of $IUDs$.

Vedclass Test Series

Exam Paper Generator

Online Exam Module

$A$: 'Saheli' - a new oral contraceptive for females was developed at $CDRI$,Lucknow.$R$: It contains no steroids.